Dow Up 0.64% Nasdaq Up 0.68%

More On TKM.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Tekmira Pharmaceuticals Corporation (TKM.TO)

-Toronto
22.88 Down 0.52(2.22%) Sep 18
Prev Close:23.40
Open:23.31
Bid:22.75
Ask:23.30
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:22.86 - 24.31
52wk Range:6.10 - 34.66
Volume:254,760
Avg Vol (3m):227,725
Market Cap:505.76M
P/E (ttm):N/A
EPS (ttm):-1.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.53
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback